Supplementary Figure S10 from BCL2 Inhibition Reveals a Dendritic Cell–Specific Immune Checkpoint That Controls Tumor Immunosurveillance

<p>Supplementary Figure S10 shows selective cDC1 depletion by cytochrome c injections, as well as the effects of cDC1 depletion on BCL2 inhibitor-induced T cell activation and fibrosarcoma control.</p>